Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside

Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors that are overexpressed on the surface of cancer cells. The radiation is used either for detection (imaging) or for destruction (therapy) of these tumors. The Division of Radiopharmaceutical Chemistry at...

Full description

Bibliographic Details
Main Authors:	Rosalba Mansi, Melpomene Fani
Format:	Article
Language:	deu
Published:	Swiss Chemical Society 2021-06-01
Series:	CHIMIA
Subjects:	clinical translation exendin-4 minigastrin somatostatin theranostics
Online Access:	https://www.ingentaconnect.com/contentone/scs/chimia/2021/00000075/00000006/art00007

id	doaj-343cb6970b6e441aa1faeb8c109cecea
record_format	Article
spelling	doaj-343cb6970b6e441aa1faeb8c109cecea2021-07-16T13:28:29ZdeuSwiss Chemical SocietyCHIMIA0009-42932673-24242021-06-0175650050410.2533/chimia.2021.500Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-BedsideRosalba Mansi0Melpomene Fani1Division of Radiopharmaceutical Chemistry, University Hospital Basel, University of Basel, CH-4031 Basel, SwitzerlandDivision of Radiopharmaceutical Chemistry, University Hospital Basel, University of Basel, CH-4031 Basel, SwitzerlandRadiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors that are overexpressed on the surface of cancer cells. The radiation is used either for detection (imaging) or for destruction (therapy) of these tumors. The Division of Radiopharmaceutical Chemistry at the University Hospital Basel has conducted pioneering work on the development of peptide-based radiopharmaceuticals. Our research covers the entire spectrum of such developments, from bench-to-bedside, and it is illustrated in this article by selective cases.https://www.ingentaconnect.com/contentone/scs/chimia/2021/00000075/00000006/art00007clinical translationexendin-4minigastrinsomatostatintheranostics
collection	DOAJ
language	deu
format	Article
sources	DOAJ
author	Rosalba Mansi Melpomene Fani
spellingShingle	Rosalba Mansi Melpomene Fani Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside CHIMIA clinical translation exendin-4 minigastrin somatostatin theranostics
author_facet	Rosalba Mansi Melpomene Fani
author_sort	Rosalba Mansi
title	Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
title_short	Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
title_full	Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
title_fullStr	Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
title_full_unstemmed	Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
title_sort	radiolabeled peptides for cancer imaging and therapy: from bench-to-bedside
publisher	Swiss Chemical Society
series	CHIMIA
issn	0009-4293 2673-2424
publishDate	2021-06-01
description	Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors that are overexpressed on the surface of cancer cells. The radiation is used either for detection (imaging) or for destruction (therapy) of these tumors. The Division of Radiopharmaceutical Chemistry at the University Hospital Basel has conducted pioneering work on the development of peptide-based radiopharmaceuticals. Our research covers the entire spectrum of such developments, from bench-to-bedside, and it is illustrated in this article by selective cases.
topic	clinical translation exendin-4 minigastrin somatostatin theranostics
url	https://www.ingentaconnect.com/contentone/scs/chimia/2021/00000075/00000006/art00007
work_keys_str_mv	AT rosalbamansi radiolabeledpeptidesforcancerimagingandtherapyfrombenchtobedside AT melpomenefani radiolabeledpeptidesforcancerimagingandtherapyfrombenchtobedside
_version_	1721297625584500736

Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside

Similar Items